People living with asthma or chronic obstructive pulmonary disease may soon have a new treatment for their symptoms.
In 2017, the Food and Drug Administrationapprovedbenralizumab as an add-on treatment for people with severe eosinophilic asthma.
The teams findings werepublishedlast week inThe Lancet Respiratory Medicine.
People taking benralizumab were significantly less likely to need further treatment for their asthma or COPD symptoms, a major clinical trial has shown.© pocketlight via Getty
So it will take larger-scale studies to confirm that benralizumab can truly manage these difficult cases.
Just this year, the FDA approved the drug foryoung children with severe asthmaandfor another condition tied to eosinophils.
This could be a game-changer for people with asthma and COPD.
News from the future, delivered to your present.
Got Sniffly Allergies?
